Stay updated on GB5121 in Refractory CNS Lymphoma Clinical Trial
Sign up to get notified when there's something new on the GB5121 in Refractory CNS Lymphoma Clinical Trial page.

Latest updates to the GB5121 in Refractory CNS Lymphoma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check21 days agoChange DetectedRevision tag updated from v3.2.0 to v3.3.1; no changes to the study details, page layout, or content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check29 days agoChange DetectedThe government funding status notice about operating status has been removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check43 days agoChange DetectedNo substantive content changes detected; the page's core details (study design, eligibility criteria, and locations) appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check71 days agoChange Detected- Added a funding/status notice and operating details for NIH Clinical Center, plus a version bump to v3.2.0. - Removed the previous version tag v3.1.0.SummaryDifference4%

- Check79 days agoChange DetectedUpdated the page from revision v3.0.2 to v3.1.0, signaling a new release version.SummaryDifference0.1%

Stay in the know with updates to GB5121 in Refractory CNS Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GB5121 in Refractory CNS Lymphoma Clinical Trial page.